Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
recombinant timothy grass pollen allergen cocktail
- Development stage
- Phase 3
- Lead developer
- Biomay
- Modality
- Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Administration
- Subcutaneous
01
Overview
Recombinant timothy grass pollen allergen cocktail is an allergen extract immunotherapy composed of a mixture (cocktail) of recombinant major allergens from timothy grass (Phleum pratense) pollen. It is designed to induce immune tolerance in individuals with IgE-mediated allergic rhinitis (hay fever) and rhinoconjunctivitis caused by grass pollen. The recombinant allergens act primarily as immunomodulators, aiming to safely desensitize patients by promoting protective immune responses (including blocking antibodies) and reducing allergic symptoms. This approach improves safety and consistency compared to natural extracts. The developer includes Biomay AG, and clinical studies have tested this cocktail in combination with aluminium hydroxide as an adjuvant for subcutaneous immunotherapy in patients with grass pollen allergies[2].
- Other names
- recombinant timothy grass pollen allergoidsrecombinant timothy grass pollen allergen cocktailhigh-dose rPhleumrPhleum
02
Targets
Group 5 grass pollen allergenPhl p (Timothy grass pollen allergen)EXPB1 (Group 1 beta-expansin)Phl p 6 (Timothy grass pollen allergen Phl p 6)
Beyond the preview
Go deeper on recombinant timothy grass pollen allergen cocktail.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on recombinant timothy grass pollen allergen cocktail.